Rubella Vaccine has 4 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Human Botulinum Neurotoxin A/B Immune Globulin, Human Immunoglobulin G, Immune Globulin Intravenous (Human) 10%. Patients taking Rubella Vaccine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Moderate
- 4
Moderate (4)
- Rubella Vaccine + Human Botulinum Neurotoxin A/B Immune Globulin— Antibodies in BabyBIG may interfere with immune response to live rubella vaccine. Vaccination should be deferred until 6…
- Rubella Vaccine + Human Immunoglobulin G— Immunoglobulin may transiently impair efficacy of live attenuated rubella vaccine due to interference with active antibo…
- Rubella Vaccine + Immune Globulin Intravenous (Human) 10%— VIGIV may impair efficacy of live attenuated rubella vaccine. Defer vaccination until approximately three months after V…
- Rubella Vaccine + Tuberculin Purified Protein Derivative— Live rubella vaccine may temporarily depress PPD reactivity. Tuberculin test should be given before vaccine, simultaneou…